Research Program: Prevention & Etiology
Assistant Professor, Department of Psychiatry
Adjunct Assistant Professor, Department of Psychology

moon0078@umn.edu
612-627-1822 — office
Preferred method of contact: e-mail

Dr. Mooney is an assistant professor of psychiatry at the University of Minnesota. He received his B.A. in psychology from Johns Hopkins University (Phi Beta Kappa), and completed his doctorate in clinical psychology at the University of Minnesota under the supervision of Dr. Dorothy Hatsukami. He completed his clinical internship and post-doctoral fellowship at the University of Texas, Houston. Before coming to the University of Minnesota, he was an assistant professor in the Department of Psychiatry at the University of California, San Francisco.

Research Interests

Dr. Mooney is supported by a National Institute of Drug Abuse (NIDA) Career Development award to advance his research in medications development for smoking cessation. His primary research goal is to create a program for smoking cessation pharmacotherapy development, particularly for complex smokers with psychiatric and substance abuse comorbidities. He is interested in the evaluation of combination or sequential pharmacotherapies as well as novel monotherapies. He is developing a human laboratory model to evaluate candidate medications for smoking cessation. In conjunction with his program of medications development, he is interested in individual factors that influence medication treatment initiation and completion, including medication knowledge, attitudes, and expectancies. He is also interested in various topics in clinical trials methodology including medication compliance and blinding. He is an associate editor of the journal Nicotine and Tobacco Research.

Selected Publications

Hatsukami, D. K., & Mooney, M. E. (1999). Pharmacological and behavioral strategies for smoking cessation. Journal of Clinical Psychology in Medical Settings, 6(1), 11-38.

Mooney, M., White, T., & Hatsukami, D. (2004). The blind spot in the nicotine replacement therapy literature: assessment of the double-blind in clinical trials. Addictive Behaviors, 29(4), 673-684.

Mooney, M., Sayre, S. L., Green, C., Rhoades, H., & Schmitz, J. (2004). Comparing measures of medication taking in a pharmacotherapy trial for cocaine dependence. Addictive Disorders & Their Treatment, 3(4), 165-173.

Schmitz, J. M., Sayre, S. L., Stotts, A. L., Rothfleisch, J., & Mooney, M. E. (2005). Medication compliance during a smoking cessation clinical trial: A brief intervention using MEMS feedback. Journal of Behavioral Medicine, 28(2), 139-147.

Mooney, M., Babb, D., Jensen, J., & Hatsukami, D. (2005). Interventions to increase use of nicotine gum: A randomized, controlled, single-blind trial. Nicotine Tob Res, 7(4), 565-579.

Mooney, M. E., Leventhal, A. M., & Hatsukami, D. K. (2006). Attitudes and knowledge about nicotine and nicotine replacement therapy. Nicotine Tob Res, 8(3), 435-446.

Mooney, M., Green, C., & Hatsukami, D. (2006). Nicotine self-administration: Cigarette versus nicotine gum diurnal topography. Human Psychopharmacology: Clinical and Experimental, 21(8), 539-48.

Hatsukami, D. K., Le, C., Zhang, Y., Joseph, J., Mooney, M., Carmella, S., et al. (2006). Toxicant exposure in cigarette reducers vs. light smokers. Cancer, Epidemiology, Biomarkers, and Prevention, 15(12), 2355-8.

Mooney, M. E., & Sofuoglu, M. (2006). Bupropion for the treatment of nicotine withdrawal and craving. Expert Rev Neurother, 6(7), 965-981.

Mooney, M. E., Sayre, S. L., Hokanson, P. S., Stotts, A. L., & Schmitz, J. M. (2007). Adding MEMS feedback to behavioral smoking cessation therapy increases compliance with bupropion: A replication and extension study. Addict Behaviors, 32(4), 875-880.

Hatsukami, D. K., Mooney, M., Murphy, S., LeSage, M., Babb, D., & Hecht, S. (2007). Effects of high dose transdermal nicotine replacement in cigarette smokers. Pharmacology, Biochemistry, and Behavior, 86, 132-139.

Mooney, M., Schmitz, J., Moeller, F. G., & Grabowski, J. (2007). Safety and tolerability of levodopa-carbidopa treatment for cocaine dependence: Two double-blind randomized clinical trials. Drug and Alcohol Dependence, 88(2-3), 214-223.

Schmitz, J.M., Stotts, A.L., Mooney, M.E., DeLaune, K.A., & Moeller, F. G. (2007). Bupropion and cognitive-behavioral therapy for smoking cessation in women. Nicotine and Tobacco Research, 9(6), 699-709.

Hecht, S., Carmella, S., Murphy, S., Riley, W., Le, C., Luo, X., Mooney, M., & Hatsukami, D. (2007). Similar uptake of a tobacco-specific carcinogens in smokeless tobacco users and smokers. Cancer Epidemiology, Biomarkers & Prevention, 16(8), 1567-1572.

Sofuoglu, M., Yoo, S., Hill, K. P., & Mooney, M. (2008). Self-administration of intravenous nicotine in male and female cigarette smokers. Neuropsychopharmacology, 33(4), 715-720.

Sofuoglu, M., Waters, A. J., & Mooney, M. (2008). Modafinil and nicotine interactions in abstinent smokers. Human Psychopharmacology, 23(1), 21-30.

Mooney, M., Reus, V. I., Gorecki, J., Hall, S., Humfleet, G., Munoz, R., & Delucchi, K. (2008). Therapeutic drug monitoring of nortriptyline in smoking cessation: A multistudy analysis. Clinical Pharmacology & Therapeutics, 83(8), 436-442.

Mooney, M., Poling, J., Gonzales, G., Gonsai, K., Kosten, T., & Sofuoglu, M. (in press). Preliminary study of buprenorphine and bupropion for opioid dependent smokers. The American Journal on Addictions.

Mooney, M., Li, Z., Murphy, S., Murphy, S., Le, C., & Hatsukami, D. (in press). Stability of the nicotine metabolite ratio in ad libitum and reducing smokers. Cancer Epidemiology, Biomarkers & Prevention.